export default function Mk677OverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        MK-677 is the only oral compound that meaningfully raises growth hormone levels &mdash; no
        injections, just a daily capsule. That&rsquo;s the real appeal. The catch is it stays active
        for about 24 hours, which means persistent elevated GH rather than brief natural pulses, and
        that amplifies every side effect: hunger all day, water retention, blood sugar pressure. Oral
        delivery doesn&rsquo;t soften the endocrine load &mdash; it extends it.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Average Person &mdash; oral GH boost without needles</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I&rsquo;ve heard GH helps with muscle and fat &mdash; can I actually get that from a pill instead of injecting?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>No needles, no reconstitution</strong><br />Every other compound in the GH-stimulating category requires mixing a powder with water and injecting yourself. MK-677 is a capsule or tablet you swallow. For anyone who wants GH-axis effects but is genuinely needle-averse, this is the only option that actually works.</li>
          <li><strong>Sleep quality and vivid dreams</strong><br />GH is released primarily during deep sleep, and MK-677 notably improves sleep depth and REM richness for most users. Vivid dreams are almost universal. People who sleep poorly often notice this effect before anything else and value it independently of any body composition effects.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The hunger is not subtle &mdash; it&rsquo;s persistent through the entire day, not just around a dose window the way injectable GH-stimulating compounds are. If you&rsquo;re eating at maintenance or in a deficit, MK-677 works directly against that by making food feel urgently necessary. Water retention and puffiness in the face and hands are common, especially early. These aren&rsquo;t signs something is wrong &mdash; they&rsquo;re the expected pharmacology. If you have any blood sugar issues or prediabetes, this isn&rsquo;t the right choice: sustained GH elevation continuously counters insulin, which injectable protocols with their short windows handle better. <strong>Net: the oral convenience is real; the tradeoffs are amplified, not softened.</strong></p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; body recomposition without injecting</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want more muscle and less fat and I&rsquo;d rather not inject daily &mdash; can MK-677 get me there?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Real GH and IGF-1 elevation that accumulates over months</strong><br />MK-677 raises both GH and IGF-1 measurably and sustainably. The lean mass and fat loss effects from GH-axis stimulation are real &mdash; they just require months of consistent use, not weeks. For an athlete who wants to see body composition shift without the logistical burden of daily injections, that&rsquo;s a genuine option.</li>
          <li><strong>Recovery and connective tissue support</strong><br />Elevated GH/IGF-1 supports tendon, ligament, and joint recovery in ways that are hard to attribute to training alone. Athletes dealing with chronic joint irritation or connective tissue stress often notice improved recovery capacity over months of use &mdash; which is consistent with GH&rsquo;s known roles in tissue repair.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Body recomposition while fighting off persistent hunger is genuinely hard. Users who don&rsquo;t account for MK-677&rsquo;s appetite pressure often see fat gain alongside any lean mass improvement &mdash; the net result isn&rsquo;t what they expected. The comparison to injectable GH-stimulating protocols is important: a bedtime injection of ipamorelin produces a pulse of GH that fades by morning, keeping appetite manageable. MK-677&rsquo;s 24-hour activity means the appetite and glucose effects are continuous. Glucose monitoring is especially relevant for athletes because sustained GH elevation &mdash; unlike a brief pulse &mdash; maintains the insulin counter-regulatory effect around the clock. <strong>Net: excellent recovery tool; body recomposition requires active caloric management that the drug actively fights.</strong></p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; GH axis optimization</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want to understand how MK-677&rsquo;s sustained ghrelin receptor activation compares to pulsatile injectable protocols and what that means for IGF-1 optimization and long-term axis dynamics.&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The only oral GH secretagogue that actually works &mdash; a unique pharmacological position</strong><br />MK-677 is not a peptide; it&rsquo;s a small molecule that mimics ghrelin at the ghrelin receptor. This structural difference is why it survives digestion and can be taken orally while all peptide GH-stimulating compounds require injection. For a biohacker mapping the GH axis toolset, MK-677 occupies a genuinely distinct pharmacological category &mdash; same receptor as ipamorelin, fundamentally different kinetics.</li>
          <li><strong>Longer human clinical trial database than most community compounds</strong><br />MK-677 has been studied in longer clinical trials than virtually any other GH-stimulating community compound &mdash; including in elderly populations and growth hormone deficiency contexts. The evidence base for its GH and IGF-1 effects is more substantiated than most. For someone evaluating GH secretagogues on evidence quality, MK-677 has comparative depth.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The sustained ghrelin receptor activation is pharmacologically meaningful: receptor desensitization dynamics over months of continuous use are not well characterized for community dosing patterns. The community convention of cycling MK-677 (typically 3&ndash;6 months on, time off) is reasonable but not derived from clinical data on healthy adults. The glucose counter-regulatory effect from continuous GH elevation is the most important safety consideration to monitor: IGF-1 labs and fasting glucose before and during use are minimum surveillance. Anyone considering stacking MK-677 with CJC-1295 or other GHRH analogs for additive GH release needs to think carefully about the compounding glucose effect. <strong>Net: the most evidence-grounded oral GH tool; requires metabolic monitoring that injectable protocols with pulsatile windows handle more naturally.</strong></p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What MK-677 is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>A lower-risk version of injectable GH secretagogues &mdash; oral delivery means 24-hour exposure, not reduced endocrine load</li>
              <li>A fat loss compound &mdash; the persistent ghrelin receptor activation drives hunger that actively works against caloric restriction</li>
              <li>A peptide &mdash; it&rsquo;s a small molecule that mimics ghrelin, which is why it survives digestion</li>
              <li>Safe for anyone with diabetes, prediabetes, or significant insulin resistance without careful glucose monitoring</li>
              <li>Something with a validated long-term healthy adult use profile &mdash; the clinical trials studied specific populations, not enhancement use</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>Genuinely the only oral option for GH-axis stimulation &mdash; a unique pharmacological position nothing else occupies</li>
              <li>Sleep quality and REM improvement are real and often felt before any body composition changes</li>
              <li>More clinical trial data than almost any other community GH compound</li>
              <li>Recovery and connective tissue effects accumulate meaningfully over months of consistent use</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
